Plain-English translation of NCT06092892 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is studying whether upfront surgery to remove the breast tumor and affected lymph nodes, followed by hormone therapy, works well for women with early-stage hormone-sensitive breast cancer that has spread to the lymph nodes. Researchers want to learn about recurrence rates and survival outcomes with this treatment approach. The study will enroll 45 women and track their progress over time.
Some women with early breast cancer have cancer cells that show up in their lymph nodes on imaging but aren't felt during a physical exam. Doctors want to understand whether treating these patients with upfront surgery and hormone therapy gives them the best chance of staying cancer-free long-term.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will undergo surgery to remove your breast tumor and affected lymph nodes, followed by hormone therapy as recommended by your doctor. The research team will collect information about your medical history, tumor characteristics, and treatment details. You will be monitored over time to track how well the treatment works and watch for any recurrence or side effects.
AI-generated summary from trial data · Aug 17, 2026 · Not medical advice
United States